Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "McKesson"


25 mentions found


Solar panel manufacturer First Solar emerged as this week's biggest gainer, with shares surging 26.3% as of Friday morning. Approximately 41% of analysts covering the stock rate it a buy, according to FactSet. To be sure, the stock is already 2.6% above analysts' consensus price target. More than half of analysts covering Albemarle rate it a buy, according to FactSet data. The stock is up approximately 15% in 2023, and analysts estimate additional 6% growth, based on the average price target.
It also reaffirmed full-year revenue guidance, though it raised its full-year adjusted EBITDA forecast. Western Digital — The chip stock rose about 2% in premarket after the company reported a revenue beat in the latest quarter. Earnings guidance for the full year was more upbeat and the company posted better-than-expected earnings and revenue, according to Refinitiv. The company reported revenue of $149.4 million against Refinitiv analyst expectations of $209.9 million. The company reported adjusted earnings of $7.19 per share, just topping a StreetAccount forecast of $7.18 per share.
Palantir – Palantir shares popped nearly 20% after the software company beat first-quarter estimates and said it anticipates full-year profitability. The firm also reaffirmed full-year revenue guidance and raised its full-year adjusted EBITDA expectations, while cutting 6% of its workforce. Under Armour — The apparel company slipped 5.3% after the company projected earnings per share and revenue to be short of Wall Street expectations for the full-year. Fisker — Shares shed 4.8% after the automotive company's first quarter earnings came in under Wall Street forecasts. Trex Company — Trex Company jumped 8.1% after the maker of wood-alternative decking and railing topped analysts' first-quarter expectations, and issued stronger-than-expected second-quarter revenue guidance.
Bank of America says healthcare stocks are usually strong performers in economic downturns. Their solid earnings and low valuations should help healthcare stocks going forward. The firm named 16 favorite stocks in the sector, including 3 that it thinks could double in price. Healthcare stocks aren't having a great year, but Bank of America says it sees signs that the tide is going to turn. Bank of America says the following 16 names are the best defensive and high-upside small- and mid-cap stocks in healthcare.
With only a small fraction of the S & P 500 left to report quarterly earnings, investors are now turning their focus to another major hurdle for the markets and economy: the debt ceiling crisis. Earlier this week, we looked back to debt limit crisis of 2011 for potential lessons. The protracted fight ultimately ended in an agreement in early August of that year, but it was a choppy summertime ride for investors. Within the portfolio, Wynn Resorts will report Tuesday, after the closing bell, and Disney will report on Wednesday, after the closing bell. Estee Lauder (EL) and Emerson Electric (EMR) reported earnings before the opening bell.
For the immediate economic and earnings and growth outlook, it almost seems irrelevant whether regional bank stocks rally, steady or sell off more next week. Regional banks were top of mind for investors this past week, as First Republic failed , the SPDR S & P Regional Banking ETF tumbled more than 10% — twice the five-day loss in the S & P 500 Energy Index, the hardest hit S & P sector — and lenders such as PacWest Bancorp and Western Alliance Bancorp lost billions in market value. And, for all that, the S & P 500 only fell about 0.75% this week. Now the conventional wisdom on Wall Street is that regardless of how the regional bank stocks trade, it's a given that bank lending officers are going to pull in their horns and risk management desks will grow more risk averse. But stocks still face a host of issues, none of which are going away next week.
Analysts are bullish on some of the stocks owned by Warren Buffet's Berkshire Hathaway . Still, some of the "Oracle of Omaha's" stocks are also well liked by analysts on Wall Street. CNBC Pro looked through his portfolio to find companies that met the following criteria: 55% or more of the analysts covering the stocks have a buy rating. Topping the list is Taiwan Semiconductor , with 83% of analysts rating it as buy and the average price target pointing to upside of 25%. The stock has buy ratings from 55.6% of analysts covering it, and the average price target suggests it could go up 40%.
The S & P 500 is "supported" by just seven mega-cap tech stocks right now — and it's starting to look a lot like the 1990s tech bubble, one analyst told CNBC on Wednesday. "The S & P 500 [is being] supported by a few expensive mega cap techs," said Eric Lynch, managing director of Scharf Investments. Seven companies — Apple , Microsoft , Nvidia , Meta , Tesla , Amazon and Alphabet — account for 95% of the S & P 500's total return in the first quarter, he noted. "To us this looks a lot like the tech bubble in 1990s when tech gave the world massive outperformance over value, over mid cap small caps, international stocks," he told CNBC's " Street Signs Asia. " Stock picks Lynch named three stocks he said are cheap right now.
Stocks with steady earnings growth are the play to manage an upcoming economic downturn, according to David Kostin, Goldman Sachs' chief U.S. equity strategist. Goldman Sachs projects that there is a 35% probability that the U.S. economy will enter a recession within the next 12 months. What's perhaps not priced in our view, would be the stable growth companies." The equity strategist named household products company Colgate-Palmolive and biotechnology name Amgen as examples of stocks with low variability of earnings growth in an environment that's laden with recession risk. The firm also picked pest-control company Rollins and consumer goods company Procter & Gamble in its basket of steady earnings growers.
Lightning round: Pioneer over Exxon, it has a better yield
  + stars: | 2023-04-04 | by ( Jim Cramer | ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailLightning round: Pioneer over Exxon, it has a better yieldMad Money host Jim Cramer weighs in on all manner of stocks, including AEHR, Solaredge, Exxon, Amprius, Goldman Sachs, Gaming and Leisure, Ready Capital Group, Ally Financial, McKesson Corp and Endeavor Group.
UBS reiterates Wells Fargo and Bank of America as buy UBS said it sees a re-rating for bank stocks such as Wells and Bank of America. Morgan Stanley names Mercadolibre a top pick Morgan Stanley said it sees multiple growth drivers for the LatAm e-commerce company. Deutsche Bank reiterates Charles Schwab as buy Deutsche said it's standing by its buy rating on shares of Charles Schwab. UBS reiterates Disney as buy UBS said it thinks Disney will take a 100% ownership stake in Hulu and integrate it with Disney+. Morgan Stanley reiterates elf Beauty as overweight Morgan Stanley said it sees a long-term growth opportunity for the beauty company.
March 1 (Reuters) - Drug distributors Cardinal Health Inc (CAH.N), McKesson Corp (MCK.N) and JM Smith Corp on Wednesday prevailed at trial in Georgia in a case brought by families of opioid addicts accusing the companies of acting as drug dealers. It was the first trial of opioid claims brought by individual plaintiffs, rather than government entities. Plaintiffs said the distributors fueled illegal opioid use by filling illegitimate pharmacy orders and failing to report suspicious opioid purchases to law enforcement, as required by the federal Controlled Substances Act. Litigation by more than 3,300 state, local and tribal governments against opioid manufacturers, distributors and pharmacies has resulted in more than $50 billion in settlements. The agency has said opioid overdoses surged further during the COVID-19 pandemic, increasing 38% in 2020 over the previous year and another 15% in 2021.
Leading fund manager Jeff Muhlenkamp put about half of his fund into cash last summer. Last summer, Jeff Muhlenkamp was so concerned about the US economy that he put nearly half of his fund's assets into cash. But in recent months, Muhlenkamp has moved more money into select stocks — even though he acknowledges that there are still lingering risks for stocks and the economy. "You're seeing buyers come back into the market," Muhlenkamp said. Lastly, Microsoft is like Apple in that it's a mature mega-cap company with profitable businesses that produce tons of cash, Muhlenkamp said.
CNBC Pro combed through top Bank of America research to find the most undervalued stocks on Wall Street. The firm says its base case is that the already "undervalued" stock can re-rate from current levels. In addition, Harley's management team is executing well with electric vehicle motorcycles on the horizon and burgeoning international growth opportunities. The says it sees "asymmetrical upside potential" meaning that when peers in the sector go up, KKR shares could go even higher. Remain Buy for undervalued growth and pipeline with two launches worth 5bn euros peak in 23E.
He screened the Russell 1000 for "valmentum" stocks that he expects will outperform and have characteristics of both growth and value. Stocks on the list have a high level of short interest, as well as good growth momentum and strong free cash flow yield, which is a value trait. It's a stock picker's market," said Emanuel, who heads Evercore ISI equity, derivatives and quantitative strategy. Airbnb has an estimated free cash flow yield of 5% and expected earnings growth this year of more than 9%. Booking's free cash flow is expected to be 5.4% this year, and its earnings are expected to grow 26.4%.
Morning Bid: A quart and two halves
  + stars: | 2023-02-01 | by ( ) www.reuters.com   time to read: +5 min
A look at the day ahead in U.S. and global markets from Mike Dolan. February kicked off on Wednesday without too much trepidation about how all that will pan out. Before the Fed announcement, ADP releases its January private sector employment readout for last month and markets will also scan the December JOLTS job openings report. While markets await the 'Triple-A' of Big Tech releases on Thursday, Meta (META.O) is due to report later today and the dour news from elsewhere in the tech sector kept coming. They do not reflect the views of Reuters News, which, under the Trust Principles, is committed to integrity, independence, and freedom from bias.
Investors will get another clue when the January jobs report is released on Friday. Economists predict that 185,000 jobs were added last month, a slowdown from the gain of 223,000 jobs in December and 263,000 in November. A further deceleration in the labor market would likely please the Fed, as it would show that last year’s rate hikes are successfully taking some air out of the economy. Along those lines, average hourly earnings, a measure of wages that is also part of the monthly jobs report, are expected to increase 4.3% year-over year. So far, tech earnings season is not off to an inspiring start, with Microsoft (MSFT), Intel (INTC) and IBM (IBM) all reporting weak results.
While only six companies in the Dow Jones Industrial Average are reporting next week, about 20% of the S & P 500 reports, making it the biggest week of earnings this season. The Dow and the S & P 500 gained 2.2% and 2.9% this week, respectively, while the Nasdaq Composite rose 4.7%. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.
The Fed's meeting Tuesday and Wednesday comes amid a flood of corporate earnings reports, with about 20% of the S & P 500 reporting that week. The most important day for earnings is Thursday, when Apple , Alphabet and Amazon report after the bell. The Nasdaq Composite was up 11% for the month as of Friday afternoon, well ahead of the 6.2% gain in the S & P 500. Traders have been watching the S & P 500 edge closer to the key threshold of 4,100 , its high from December. AAPL 1Y line apple Apple is also important because of the signals it can send about the strength of the consumer, supply chains and China's reopening.
[1/5] Boxes containing the Moderna COVID-19 vaccine are prepared to be shipped at the McKesson distribution center in Olive Branch, Mississippi, U.S. December 20, 2020. Senator Bernie Sanders sent Moderna Inc (MRNA.O) a letter this week asking the drug company to halt planned U.S. price increases on its COVID-19 vaccine, saying price hikes could make the shot unaffordable for millions of Americans. Sanders said in his letter that raising prices would be particularly egregious after the U.S. government provided around $1.7 billion to fund development of the vaccine. The Vermont senator has railed against high drug prices and backed Medicare-for-all, and his chairmanship of the HELP committee could put drug companies in his crosshairs. Moderna's COVID-19 vaccine sales were around $18.4 billion in 2022.
Mega cap stock abandonment: Lots of hedge funds surprised Club holding Apple (AAPL) didn't go higher after it didn't preannounce. Club holding Costco (COST) says net sales of $23.8 billion for December rose 7% year over year. Guggenheim raises price target on Club holding Starbucks (SBUX) to $103 per share from $92; keeps hold-equivalent rating. Wells Fargo says the negativity is too great when it comes to PVH Corp (PVH) but raises price target and stock rating to a buy-equivalent. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.
CNBC's Jim Cramer on Wednesday offered investors a selection of stocks that he believes will do well this year. To come up with his picks, he examined the best- and worst performers in the S&P 500 from last year and chose five potential 2023 winners from each list. Here are the best-performers from 2022 that Cramer believes could continue to see gains this year:HalliburtonCramer predicted that the stock has a multi-year rally ahead of it. Enphase EnergyCalling it the "renewable golden boy," Cramer said the solar energy technology company is a profitable, solid business. Northrop GrummanThe company's stock could be the best defense contractor to own as the war between Russia and Ukraine continues, according to Cramer.
Warren Buffett's Berkshire Hathaway wasn't immune from the 20% stock market sell-off in 2022. These were Buffett's 10 best performing stocks owned by Berkshire Hathaway in 2022. The worst performing stocks owned by Berkshire Hathaway in 2022 included Nu Holdings and Snowflake, which both sank 57%. These were the 10 best performing stocks owned by Berkshire Hathaway in 2022. The list also includes a Berkshire holding value as of September 30, and is according to data from Whale Wisdom.
I noted last week that there is an unusual divergence in thinking among Wall Street strategists for earnings and prices in 2023. Yet, in 2023, strategists do not seem to agree on this. A survey of 22 strategists indicated the average price target for the S & P 500 for year-end 2023 was 4,078. That would be about 7% higher than where the S & P is now. It means "patient accumulation" of what seems like odd choices, including China ADRs and what Emanuel calls "Misperceived Value" stocks.
WASHINGTON, Dec 29 (Reuters) - The U.S. government on Thursday filed a lawsuit accusing AmerisourceBergen Corp (ABC.N), one of the nation's largest drug distributors, of helping ignite the nation's deadly opioid epidemic by failing to report hundreds of thousands of suspicious orders of prescription painkillers. The government said AmerisourceBergen had since 2014 systematically refused or negligently failed to flag suspicious orders by pharmacy customers when it had reason to know that opioids were being diverted to illegal channels. "For years, AmerisourceBergen prioritized profits over its legal obligations and over Americans' well-being," Associate Attorney General Vanita Gupta told reporters. In a statement, AmerisourceBergen called the lawsuit an improper attempt to "shift blame" and the burdens of law enforcement from the Justice Department and DEA to the companies they regulate. The Justice Department said AmerisourceBergen for years understaffed and unfunded programs designed to ensure compliance with the Controlled Substances Act.
Total: 25